CASC2 and neoplasm: Later on, CASC2 was unveiled to be a tumor suppressor gene in endometrial, colorectal, lung, and renal cancers and gliomas, probably behaving as ceRNAs by buffering miR-21 and miR-18a, two microRNAs with oncogenic effects [9, 130–133].